Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Y Vanrenterghem

Showing results (1-10 of 187) with videos related to

Pageof 19
Sort By:
Lancet (London, England)|August 19, 2000
Cautious approach to use of non-heart-beating donorsY Vanrenterghem
Acta Clinica Belgica|January 1, 1986
The evaluation of asymptomatic microscopic haematuriaY Vanrenterghem
Nephron|January 1, 1997
The use of Mycophenolate Mofetil (Cellcept) in renal transplantationY Vanrenterghem
Transplantation Proceedings|November 27, 1999
Vascular rejection with tacrolimus and potential long-term graft outcomeY Vanrenterghem
European Radiology|January 1, 1997
Lymphoproliferative disorders in organ transplant recipientsY Vanrenterghem
Transplantation Proceedings|June 24, 1998
Role of acute rejection in chronic rejectionY Vanrenterghem
Contributions to Nephrology|October 8, 1998
The use of mycophenolate mofetil (Cellcept) in renal transplantationY Vanrenterghem
Transplantation Proceedings|September 2, 1998
Tacrolimus (FK 506) in kidney transplantationY Vanrenterghem
Transplantation Proceedings|January 5, 2000
Strategies to reduce or replace steroid dosingY Vanrenterghem
Transplantation|October 5, 2001
Posttransplant cardiovascular risk: impact on long-term patient survival. IntroductionY Vanrenterghem
Pageof 19

Showing results (1-10 of 187) with videos related to

Sort By:
Pageof 19
Lancet (London, England)|August 19, 2000
Cautious approach to use of non-heart-beating donorsY Vanrenterghem
Acta Clinica Belgica|January 1, 1986
The evaluation of asymptomatic microscopic haematuriaY Vanrenterghem
Nephron|January 1, 1997
The use of Mycophenolate Mofetil (Cellcept) in renal transplantationY Vanrenterghem
Transplantation Proceedings|November 27, 1999
Vascular rejection with tacrolimus and potential long-term graft outcomeY Vanrenterghem
European Radiology|January 1, 1997
Lymphoproliferative disorders in organ transplant recipientsY Vanrenterghem
Transplantation Proceedings|June 24, 1998
Role of acute rejection in chronic rejectionY Vanrenterghem
Contributions to Nephrology|October 8, 1998
The use of mycophenolate mofetil (Cellcept) in renal transplantationY Vanrenterghem
Transplantation Proceedings|September 2, 1998
Tacrolimus (FK 506) in kidney transplantationY Vanrenterghem
Transplantation Proceedings|January 5, 2000
Strategies to reduce or replace steroid dosingY Vanrenterghem
Transplantation|October 5, 2001
Posttransplant cardiovascular risk: impact on long-term patient survival. IntroductionY Vanrenterghem
Pageof 19